Supriya Lifesciences received GMP certification from ANVISA Brazil
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Subscribe To Our Newsletter & Stay Updated